US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

29.07

0.0000

Volume:17

Turnover:493.61

Market Cap:1.02M

PE:- -

High:29.07

Open:29.07

Low:29.07

Close:29.07

52wk High:29.88

52wk Low:24.32

Shares:35.00K

Float Shares:35.00K

Volume Ratio:0.09

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Estee Lauder, University of Leeds Collaborate to Improve Foundation Shade Matching

MT Newswires Live

Estée Lauder Partners with University of Leeds to Advance Complexion Shade-Matching Research

The EstÉE Lauder Companies and University of Leeds Partner to Advance the Future of Complexion Shade Matching

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

Kimberly-Clark Names Suzana Blades Senior Vice President, General Counsel

Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

THOMSON REUTERS

Angelalign to Appeal China Court Ruling on Premolar Extraction Solution Patent Dispute

As Hims Prepares for Peptides Launch, Wall Street Cautious on Prospects This Year

Analysts Offer Insights on Consumer Goods Companies: Westrock Coffee (WEST) and The Estée Lauder Companies (EL)

Align Technology Prevails in China Patent Infringement Action

MT Newswires Live

Align Wins China Court Ruling Against Angelalign over Extraction-Gap-Closure Patent, Awarded RMB 10 Million

Kenvue Price Target Cut to $19.00/Share from $20.00 by UBS

What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?

Simply Wall St.

Apogee Shareholders Approve AbbVie Acquisition and Leadership Transition

Apogee Therapeutics Gelar Rapat Khusus Pemegang Saham Lewat Webcast Langsung

Sector Update: Healthcare

MT Newswires Live

3 Stocks Estimated To Be Undervalued In August 2026

Simply Wall St.

Hims & Hers Health Price Target Raised to $32.00/Share from $30.00 by B of a Securities

AbbVie Targets Key Lung Cancer Market With New Phase 3 ABBV-1480 Trial

Hims & Hers Revenue Upside Tempered by Margin Concerns

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/GLAM/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":29.073,"timestamp":1787670485278,"preClose":29.073,"halted":0,"volume":17,"delay":0,"changeRate":0,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"08-25 12:19:04 EDT","open":29.073,"high":29.073,"low":29.073,"amount":493.61366599999997,"amplitude":0,"askPrice":29.08,"askSize":1400,"bidPrice":29.03,"bidSize":1400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":29.073,"nav":28.91,"aum":1011850,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29.073,"latestTime":"17:51 EDT","volume":5,"amount":145.852,"timestamp":1787608315034,"change":-0.073,"changeRate":-0.002511,"amplitude":0},"volumeRatio":0.091335,"impliedVol":0.2298,"impliedVolPercentile":0.0882},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.091335,"shares":35000,"dividePrice":0,"high":29.073,"amplitude":0,"preClose":29.073,"low":29.073,"week52Low":24.3178,"pbRate":"--","week52High":29.88,"institutionHeld":0,"latestPrice":29.073,"eps":0,"divideRate":0,"volume":17,"delay":0,"ttmEps":0,"open":29.073,"prevYearClose":25.82,"prevWeekClose":28.9156,"prevMonthClose":27.9767,"prevQuarterClose":27.6454,"fiveDayClose":27.9474,"twentyDayClose":28.7157,"sixtyDayClose":24.7324},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659731144","title":"Estee Lauder, University of Leeds Collaborate to Improve Foundation Shade Matching","url":"https://stock-news.laohu8.com/highlight/detail?id=2659731144","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659731144?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:28","pubTimestamp":1786714130,"startTime":"0","endTime":"0","summary":"Estee Lauder  has formed a research partnership with the University of Leeds' School of Design in the UK to improve the matching of foundation and concealer shades, the cosmetics company said Friday.The collaboration aims to create products with more precise shade matching and better formulas, Estee Lauder said.Financial details weren't provided.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4533","GLAM","LU2404859667.USD","BK4588","LU0690374615.EUR","LU2552382132.HKD","LU2404859741.USD","LU2264538146.SGD","LU1988902786.USD","LU2552382058.USD","BK4585","LU0690374961.EUR","BK4183","BK4558","BK4548","EL","BK4504","LU1064131342.USD","LU2552382215.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659141076","title":"Estée Lauder Partners with University of Leeds to Advance Complexion Shade-Matching Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2659141076","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659141076?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:00","pubTimestamp":1786712428,"startTime":"0","endTime":"0","summary":"Estée Lauder partners with University of Leeds to advance complexion shade-matching researchEstée Lauder launched a research collaboration with the University of Leeds to improve complexion shade matc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1ZWYK1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4585","BK4504","EL","LU2404859667.USD","LU2552382215.SGD","BK4588","LU0690374961.EUR","GLAM","LU2552382058.USD","LU0690374615.EUR","LU1064131342.USD","LU1988902786.USD","BK4558","LU2552382132.HKD","BK4533","LU2404859741.USD","BK4548","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659014109","title":"The EstÉE Lauder Companies and University of Leeds Partner to Advance the Future of Complexion Shade Matching","url":"https://stock-news.laohu8.com/highlight/detail?id=2659014109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659014109?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:00","pubTimestamp":1786712400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA7F1K75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU2264538146.SGD","LU2404859667.USD","GLAM","LU2552382132.HKD","BK4548","LU2404859741.USD","BK4183","BK4558","LU1988902786.USD","LU1064131342.USD","BK4504","BK4533","LU0690374615.EUR","EL","LU2552382058.USD","LU2552382215.SGD","LU0690374961.EUR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663051","title":"Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663051?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:50","pubTimestamp":1786636209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), AbbVie (ABBV) and Esta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930573.SGD","LU0198837287.USD","LABU","IE0009355771.USD","LU1934455194.USD","LU0965509010.AUD","LU0124676726.USD","FHLC","IE00B4R5TH58.HKD","BK4559","IYH","LU0965508806.USD","PPH","PJP","SG9999011175.SGD","LU2237443978.SGD","LU0795875169.SGD","XLV","IE00BLSP4239.USD","JDOC","HCSG","LQDA","TRUH","AGNG","LU0942090050.USD","LU2089283258.USD","IXJ","LU0256863811.USD","LU0058720904.USD","IE00BN8TJ469.HKD","SG9999015978.USD","MEDX","IE00BVYPNW00.USD","BK4585","FTXH","RXL","XBI","VHT","LU0545039389.USD","GLAM","IE000F7OJYX1.SGD","LU0965509283.SGD","LU0949170772.SGD","LU1989772840.SGD","LU0738911758.USD","LU2125909247.SGD","IE0004445239.USD","ESTA","ABBV","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659570411","title":"Kimberly-Clark Names Suzana Blades Senior Vice President, General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2659570411","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659570411?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:25","pubTimestamp":1786627553,"startTime":"0","endTime":"0","summary":"Kimberly-Clark names Suzana Blades senior vice president, general counselKimberly-Clark named Suzana Blades senior vice president, general counsel effective Sept. 1, 2026; she reports to Jeff Melucci.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLbK1JSF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","LU0630314457.HKD","IXC","KVUE","LU2462591277.SGD","BK4585","IGE","TRUN","LU0648000940.SGD","LU2360032135.SGD","BK4504","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B2Q91V27.USD","VDE","LU0792757196.USD","LU1988902786.USD","DIG","SG9999001440.SGD","LU1201861165.SGD","IE00BGHQF524.EUR","LU1267930813.SGD","LU0648001328.SGD","BK4570","IEO","WEEI","LU1506573853.SGD","LU0211327993.USD","IE00B3T34201.USD","GLAM","FENY","LU0708994859.HKD","KMB","LU0130103400.USD","TEXU","IYE","IE00B7SZLL34.SGD","LU1064131342.USD","FTXN","GXPE","FCG","LU1815333072.USD","BK4213","LU0029864427.USD","IE00B19Z3581.USD","SG9999002521.SGD","XLE","RSPS","OILT","COP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659570181","title":"Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2659570181","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659570181?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:25","pubTimestamp":1786627500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA1JMCH5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0792757196.USD","BK4183","LU1267930573.SGD","BK4567","IE00BFXG1179.USD","LU0889566641.SGD","LU1267930813.SGD","IE00B3T34201.USD","LU1585245621.USD","LU2463526074.USD","LU1430594728.SGD","BK4585","BK4504","BK4588","KVUE","SG9999001440.SGD","LU0128525929.USD","RSPS","KMB","LU0029864427.USD","GLAM","LU0708994859.HKD","BK4018","LU0310800379.SGD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659654180","title":"Angelalign to Appeal China Court Ruling on Premolar Extraction Solution Patent Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2659654180","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659654180?lang=en_us&edition=fundamental","pubTime":"2026-08-13 11:53","pubTimestamp":1786593231,"startTime":"0","endTime":"0","summary":"Angelalign to appeal China court ruling on premolar extraction solution patent disputeAngelalign Technology plans to appeal an Aug. 10 first-instance ruling by a Jinan court over alleged patent infrin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL49g72V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK1593","BK4534","LU2023250843.SGD","BK4585","LU2106854487.HKD","06699","BK1587","BK4588","BK4504","LU1917777945.USD","ALGN","LU2023250504.SGD","BK1100","LU1974910355.USD","BK1583","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659902803","title":"As Hims Prepares for Peptides Launch, Wall Street Cautious on Prospects This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659902803","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659902803?lang=en_us&edition=fundamental","pubTime":"2026-08-13 02:31","pubTimestamp":1786559490,"startTime":"0","endTime":"0","summary":"As Hims prepares for peptides launch, Wall Street cautious on prospects this yearNEW YORK, Aug 12 (Reuters)-Hims & Hers Health plans to offer some legally available peptides in 2026, but investors and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4480V7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIYY","HEAL","HIMY","HIMZ","HMYY","GLAM","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658710905","title":"Analysts Offer Insights on Consumer Goods Companies: Westrock Coffee (WEST) and The Estée Lauder Companies (EL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658710905","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658710905?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:50","pubTimestamp":1786546210,"startTime":"0","endTime":"0","summary":"Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Westrock Coffee (WEST) and The Estée Lauder Co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-westrock-coffee-west-and-the-estee-lauder-companies-el-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-westrock-coffee-west-and-the-estee-lauder-companies-el-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","WEST","LU1988902786.USD","LU2404859741.USD","LU2264538146.SGD","BK4585","LU2404859667.USD","BK4588","BK4558","LU0690374615.EUR","BK4548","BK4183","LU2552382058.USD","LU1064131342.USD","BK4504","LU2552382215.SGD","GLAM","LU2552382132.HKD","LU0690374961.EUR","BK4212","EL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927255","title":"Align Technology Prevails in China Patent Infringement Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927255","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927255?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:19","pubTimestamp":1786522799,"startTime":"0","endTime":"0","summary":"Align Technology  disclosed late Tuesday that the Jinan Intermediate People's Court in China issued a judgment in its favor, in a patent infringement action against Angelalign Technology's operating subsidiaries in China.The company provides an orthodontic treatment system that straightens teeth using a series of custom-made, clear plastic aligners, instead of metal braces, through a global distribution network.In September 2025, Align filed a patent infringement action against Angelalign in Jinan Intermediate People's Court, asserting that its patented orthodontic treatment system had been infringed by the China-based Angelalign Technology.The Jinan Intermediate People's Court on Monday court ordered Angelalign Technology to cease using the patented technology and to stop manufacturing and selling the infringing products in China, and awarded damages of $1.48 million, said Align Technology.The ruling is subject to appeal, but Align Technology said it \"believes the decision further rei","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1917777945.USD","LU2106854487.HKD","LU1974910355.USD","LU2023250843.SGD","BK4198","GLAM","LU2023250504.SGD","BK4534","BK4504","BK4585","BK4588","ALGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994281","title":"Align Wins China Court Ruling Against Angelalign over Extraction-Gap-Closure Patent, Awarded RMB 10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994281","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994281?lang=en_us&edition=fundamental","pubTime":"2026-08-12 08:47","pubTimestamp":1786495652,"startTime":"0","endTime":"0","summary":"Align wins China court ruling against Angelalign over extraction-gap-closure patent, awarded RMB 10 millionA China court ruled Angelalign infringed Align Technology’s patent CN113693748B covering extr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL5CtkwQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","06699","LU2106854487.HKD","BK4504","BK4534","BK1593","BK1587","LU1917777945.USD","LU1974910355.USD","LU2023250504.SGD","BK4588","ALGN","BK4585","LU2023250843.SGD","BK1100","BK1583","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946873","title":"Kenvue Price Target Cut to $19.00/Share from $20.00 by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946873","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946873?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:08","pubTimestamp":1786482480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KVUE/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","BK4585","LU0792757196.USD","LU1267930813.SGD","IE00BFXG1179.USD","LU0029864427.USD","LU0889566641.SGD","LU1267930573.SGD","RSPS","BK4183","IE00B3T34201.USD","BK4588","KVUE","LU0128525929.USD","LU0310800379.SGD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946437","title":"What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946437?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:45","pubTimestamp":1786481115,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE:ABBV) said the FDA has accepted for review a supplemental Biologics License Application for BOTOX Cosmetic to treat masseter muscle prominence in the U.S.\nThe filing positions BOTOX Cosmetic as a potential first approved neurotoxin for this jawline contouring indication, expanding AbbVie’s facial aesthetics reach beyond wrinkle treatment.\nAbbVie is seeking to build on Phase 3 data that supported efficacy and safety in adults seeking non surgical jawline contouring...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/what-is-abbvie-abbv-poised-to-gain-from-fda-review-of-new-bo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/what-is-abbvie-abbv-poised-to-gain-from-fda-review-of-new-bo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2089284900.SGD","LU2237443465.HKD","SG9999001440.SGD","PPH","GLAM","LU1670627923.USD","LU0310800379.SGD","IXJ","LU1061106388.HKD","LU0198837287.USD","JDOC","LU0128525929.USD","LU0234570918.USD","LU1496350171.SGD","LU2089283258.USD","LU0289739699.SGD","LU1074936037.SGD","XLV","LU2125909593.SGD","ABBV","IE00BFTCPJ56.SGD","LU0203345920.USD","RXL","LU0965508806.USD","IE0009355771.USD","LU2237443622.USD","IE0000B7K699.USD","IE000BZT7R73.USD","FTXH","BK4534","LU0882574055.USD","LU0868494708.USD","IYH","LABU","LU0289961442.SGD","LU1732799900.SGD","TRUH","LU2237443895.HKD","MEDX","VHT","IE0002270589.USD","IE00BJJMRZ35.SGD","IE00BVYPNW00.USD","PJP","IE000SO60NU8.SGD","LU2347655156.SGD","AGNG","LU2089984988.USD","FHLC","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658294569","title":"Apogee Shareholders Approve AbbVie Acquisition and Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2658294569","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658294569?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:40","pubTimestamp":1786480815,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics ( ($APGE) ) has provided an update. On August 11, 2026, Apogee Therapeutics held a virtual special meeting of stockholders to v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apogee-shareholders-approve-abbvie-acquisition-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apogee-shareholders-approve-abbvie-acquisition-and-leadership-transition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABBV","IE00BJT1NW94.SGD","FHLC","LU1670627923.USD","VHT","GLAM","LU2237443382.USD","LU0395794307.EUR","LU0256863902.USD","XLV","LU0128525929.USD","LU0868494708.USD","LU0545039389.USD","IE0002141913.USD","LU2357627491.SGD","LU2133065610.SGD","AGNG","LU0203347892.USD","LU1551013342.USD","LU1291159041.SGD","TRUH","LU1037948541.HKD","RXL","LU0289739343.SGD","SG9999015986.USD","IXJ","LU1839511570.USD","LU0912757837.SGD","LU1989772923.USD","LU0795875169.SGD","IE00B2B36J28.USD","IYH","LU1585245621.USD","PJP","LU0211327993.USD","LU0057025933.USD","LU0708994859.HKD","LU2468319806.SGD","LU1093756168.USD","LU1162221912.USD","LU2347655156.SGD","LU1670628061.USD","LU0098860793.USD","MEDX","JDOC","SG9999015952.SGD","LU0820561818.USD","PPH","LU1267930490.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948566","title":"Apogee Therapeutics Gelar Rapat Khusus Pemegang Saham Lewat Webcast Langsung","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948566?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:03","pubTimestamp":1786478583,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics gelar rapat khusus pemegang saham lewat webcast langsungApogee Therapeutics menggelar rapat khusus pemegang saham pada 11 Agustus 2026 untuk membahas transaksi merger yang diusulka","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLRjqrs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","FTXH","IE00B3PB1722.GBP","LU0114720955.EUR","LU0256863811.USD","IE000MB6IJN5.SGD","LU0689472784.USD","PPH","BK4581","LU0417517546.SGD","LU1244550221.USD","IE000SO60NU8.SGD","LU1003077747.HKD","GLAM","RXL","SG9999003800.SGD","IE00B2B36J28.USD","LU0310800379.SGD","IYH","LU0124676726.USD","XLV","LU0289961442.SGD","FHLC","LU0949170772.SGD","JDOC","LU1496350502.SGD","ABBV","MEDX","LU1670627923.USD","LU0256863902.USD","LU2129689605.HKD","IXJ","SBIO","IE000F7OJYX1.SGD","IE0009355771.USD","LU0158827948.USD","LU0053671581.USD","LU0395794307.EUR","TRUH","LU2347655073.USD","IE00BGHQF631.EUR","AGNG","LU1162221912.USD","PJP","IE00B42XCP33.USD","LU0234572021.USD","VHT","APGE","IE00BSNM7G36.USD","IE00BVYPNW00.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658644912","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2658644912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658644912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:15","pubTimestamp":1786468518,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.4%.The iShares Biotechnology ETF  rose 0.3%In corporate news, Hims & Hers Health  shares were down 3.8% following its Q2 results. The results were mixed, with upside in its US business from branded GLP-1 strength and a ramp in testosterone offset by disappointing gross margin and weak free cash flow, Morgan Stanley said in a note.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2028103732.USD","LU1244550494.USD","LU1989772840.SGD","LU1668664300.SGD","LU2089283258.USD","LU0971096721.USD","LU1732800096.USD","LU1244550221.USD","LU0390134368.USD","LU1162221912.USD","LU2487616109.SGD","BK4196","LU0314104364.USD","LU0158827948.USD","LU0106831901.USD","LU1720051017.SGD","LU2271345857.HKD","LU0098860793.USD","LU2347655156.SGD","LU1548497426.USD","LU0912757837.SGD","LU2089284900.SGD","XLV","BK4588","LU0006306889.USD","LU0882574139.USD","IE00B3S45H60.SGD","LU0158827781.USD","LU0557290698.USD","BK4585","BK4516","LU0267386448.USD","LU1988902786.USD","HIYY","LU1989772923.USD","LU1074936037.SGD","MS","GLAM","HIMY","LU0528227936.USD","LU0225283273.USD","LU1791710400.SGD","LU1791710582.SGD","LU0106261372.USD","IE00BZ1G4Q59.USD","BK4127","IE00B775SV38.USD","IE00BKVL7J92.USD","HIMS","BK4581","LABU","BK4534","LU2357305700.SGD","HMYY","LU2133065610.SGD","HIMZ","LU2023251221.USD","LU1363072403.SGD","IBB","LU0053666078.USD","HEAL","LU0234570918.USD","LU0320765646.SGD","LU2111349929.HKD","LU1244550577.SGD","THNR","LU0210528500.USD","BK4504","LU1064131342.USD","IAI","LU1720051108.HKD","XBI","KBWB","LU1732799900.SGD","LU2264538146.SGD","LU0795875169.SGD","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658446912","title":"3 Stocks Estimated To Be Undervalued In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658446912","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658446912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:08","pubTimestamp":1786468082,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 2.2%, contributing to a remarkable 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying undervalued stocks can offer potential opportunities for investors looking to capitalize on companies that may be trading below their intrinsic value despite strong market performance.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4214000-choice1-main-header/1585186691957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-services/nasdaq-blmn/bloomin-brands/news/3-stocks-estimated-to-be-undervalued-in-august-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nasdaq-blmn/bloomin-brands/news/3-stocks-estimated-to-be-undervalued-in-august-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TMSL","ALRS","BK4548","HAWK","ZETX","HEAL","CNAV","CECO","J","DISK","PTF","MELI","LU1804176565.USD","THNR","WDAY","ZETA","OPTZ","BK4566","BK4581","SCHA","HIMS","LU0106959298.USD","HIMY","SYM","IE00B66KJ199.SGD","LU0354030511.USD","BK4122","GLAM","SNDG","SNDU","SYM.AU","FCUS","KMLI","CCB","ONLN","LU1868838027.USD","QQQG","SNXX","HIYY","HIMZ","FSMD","HMYY","SNDQ","IE00BFMHRM44.USD","IE00B19Z4B17.USD","SCHM","BLMN","SNDC","SNDK","COWG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658819912","title":"Hims & Hers Health Price Target Raised to $32.00/Share from $30.00 by B of a Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658819912","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658819912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:59","pubTimestamp":1786467540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HIMS/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIMZ","HIMS","GLAM","BK4196","HEAL","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658791472","title":"AbbVie Targets Key Lung Cancer Market With New Phase 3 ABBV-1480 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658791472","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658791472?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:30","pubTimestamp":1786465853,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. The phase 3 AbbVie (ABBV) study, officially titled “A Randomized, Multiregional...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-key-lung-cancer-market-with-new-phase-3-abbv-1480-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-key-lung-cancer-market-with-new-phase-3-abbv-1480-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","LU2112291526.USD","IE00BVYPNW00.USD","LU1291159041.SGD","LU0203347892.USD","LU1093756168.USD","RXL","LU2129689431.USD","ABBV","LU1074936037.SGD","LU0211328371.USD","LU1267930490.SGD","VHT","LU0661504455.SGD","SG9999015952.SGD","XLV","PJP","FHLC","AGNG","GLAM","LU0289739343.SGD","SG9999015945.SGD","LU0689472784.USD","PPH","IYH","LU0820561818.USD","LU0456855351.SGD","LU2087621335.USD","TRUH","IE00B3PB1722.GBP","IE00B2B36J28.USD","LU0689626769.HKD","LU0310800379.SGD","LU0124676726.USD","BK4585","LU1244550494.USD","LU2237443978.SGD","IE00BGHQF631.EUR","LU1496350171.SGD","IE00BN8TJ469.HKD","IXJ","FTXH","IE0002270589.USD","LU0823416689.USD","MEDX","LU0395794307.EUR","JDOC","IE0004445239.USD","IE00B19Z3B42.SGD","IE0000B7K699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658149559","title":"Hims & Hers Revenue Upside Tempered by Margin Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2658149559","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658149559?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:17","pubTimestamp":1786465020,"startTime":"0","endTime":"0","summary":"12:17 ET -- Hims & Hers Health is showing off an impressive growth trajectory for revenue that's being undercut by profitability concerns, Truist analysts say in a research note. The telehealth company raised its full-year revenue outlook on the back of its international expansion and shift toward branded weight-loss drugs, the analysts say. Most of the raise came from the inclusion of Hims' recent acquisition of Eucalyptus, they say. But investors are still debating whether the company can hit profit targets for the second half of the year, they say. Gross margins dropped in 2Q because selling third-party branded GLP-1s yields lower margins than the company's traditional compounded treatments, the analysts say, reiterating their hold rating on the stock. Shares slip 2.5% to $30.97.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","GLAM","HMYY","THNR","BK4196","HIYY","HIMS","HIMZ","HIMY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}